Osamu Hayaishi
Research History
‚P DISCOVERY OF OXYGENASE School of Medicine, Osaka Imperial University, Japan

In Japan, there remained only poor instruments and reagents for research immediately after World War II. However, Dr. Hayaishi enthusiastically looked for novel microorganisms that could survive and grow in a simple medium supplemented with several amino acids. Under these adverse conditions, Dr. Hayaishi identified several microorganisms in the soil and started experiments to clarify the mechanisms of metabolism by using tryptophan that was a gift from his mentor, Professor Kotake, at Osaka Imperial University.

Firstly Dr. Hayaishi identified an enzyme that catalyzed the conversion of catechol to muconic acid by oxidative cleavage, and he named the enzyme gPyrocatechaseh. This was the first discovery of an enzyme that cleaved the benzene ring under aerobic conditions. Then he categorized and named such enzymes goxygenaseh by using the strategy of examining the incorporation of a tracer, heavy molecular oxygen, 18O2 into the substrate on catalysis.

Assistant Professor, Department of Microbiology, Washington University School of Medicine, St. Louis, Missouri, U.S.A.
Chief, Section of Toxicology, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Maryland, U.S.A.
2 DISCOVERY OF POLY- AND MONO (ADP-RIBOSYL) ACTION Professor, Department of Medical Chemistry, Kyoto University, Japan

Almost all organisms have common systems for intake of oxygen into their metabolic pathways. With his colleagues, Dr. Hayaishi expanded the study of oxygenase phylogenetically. They successfully identified a number of oxygenases from animals, plants, and microorganisms, and determined the protein structures of some of them by crystallography. They also elucidated numerous metabolic pathways of physiological importance and demonstrated the ubiquitous presence of oxygenases. For example, they succeeded in demonstrating that the NAD, the well-known coenzyme of many dehydrogenases, could serve as an ADP-ribosyl donor in a unique type of covalent modification of proteins. Moreover, his findings were applied to the analysis of neurotransmitter and local hormones, namely prostaglandins.

3 THE ANALYSIS OF SLEEP MECHANISM (ROLES OF PROSTAGLANDINS D2 AND E2) PGE2 had been already known as a substance to cause a fever, and PGD2 was known as an isomer of PGE2.
While studying the effect of PGD2 on brain temperature, Dr. Hayaishi and his staff happened to find that PGD2 is a natural or physiological sleep-promoting substance and that PGE2 induces wakefulness.
Project Director, Hayaishi Bioinformation Transfer Project, Research Development Corporation of Japan (presently:Japan Science and Technology Corporation)
4 MOLECULAR MECHANISMS OF SLEEP-WAKE REGULATION Director, Osaka Bioscience Institute, Japan Prostaglandin synthase (PGDS) is mainly localized in the arachnoid membrane and choroid plexus, from which it is secreted into the cerebrospinal fluid together with PGD2. The latter exerts its somnogenic activity by binding to PGD2 receptors exclusively localized at the ventro-rostral surface of the basal forebrain. Concurrent with sleep induction, striking expression of Fos immunoreactivity was observed in the ventrolateral preoptic area (VLPO). These observations show that PGD2 may induce sleep via leptomeningeal PGD2 receptors with subsequent activation of the VLPO neurons.
Dr. Hayaishi's passion for research never fades away. He continues to conduct research on "Sleep" with young researchers of his grandchildren's age.
Director Emeritus, Osaka Bioscience Institute, Japan
@Hayaishi(TOP)/OBI WEB Site@